RxDoctor Payments Data

Nneoma Onyedimma, DO

Family Medicine · Jacksonville, FLNPI 1841869682

Payments from drug & device makers

$1,988in general payments, 2019–2025

Across 78 payments — averaging $25.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$271
  • Edwards Lifesciences$199
  • Boehringer Ingelheim$196
  • Novo Nordisk$168
  • Astellas Pharma US Inc$155
  • GSK$141
  • plus $858 from 15 others

What the payments were for

  • Food & beverage$1,88895%
  • Education$1005%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,988 in reported general payments places this provider in the 75th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$9,506
Medicare patients
42
Services billed
143

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide20$20,576
SymbicortBudesonide/Formoterol Fumarate13$2,919
Gabapentin35$1,182
Albuterol Sulfate HfaAlbuterol Sulfate21$518
Fluticasone Propionate18$470
Losartan Potassium40$452
Montelukast Sodium16$444
Nifedipine ErNifedipine17$342
Amlodipine Besylate34$307
Atorvastatin Calcium25$211
Metformin Hcl ErMetformin Hcl12$181
Omeprazole13$146
Hydrochlorothiazide19$84
Pantoprazole Sodium15$71
Levothyroxine Sodium11$62

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$168$20,57620 claims
AstraZenecaSymbicort$70$2,91913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →